Volume 8, Issue 3, Pages 219-225 (March 2007) Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial  Prof Miguel Martín, Amparo Ruiz, MD, Monserrat Muñoz, MD, Ana Balil, MD, Jesús García-Mata, MD, Lourdes Calvo, MD, Eva Carrasco, MD, Esther Mahillo, PhD, Antonio Casado, MD, José Ángel García-Saenz, MD, M José Escudero, BSc, Vicente Guillem, MD, Carlos Jara, MD, Nuria Ribelles, MD, Fernando Salas, MD, Celia Soto, MD, Flavia Morales-Vasquez, MD, César A Rodríguez, MD, Encarna Adrover, MD, José Ramón Mel, MD  The Lancet Oncology  Volume 8, Issue 3, Pages 219-225 (March 2007) DOI: 10.1016/S1470-2045(07)70041-4 Copyright © 2007 Elsevier Ltd Terms and Conditions

Figure 1 Trial profile *All patients who had signed a consent form were deemed as screened. The Lancet Oncology 2007 8, 219-225DOI: (10.1016/S1470-2045(07)70041-4) Copyright © 2007 Elsevier Ltd Terms and Conditions

Figure 2 Kaplan-Meier curves for progression-free survival See Online for webtable The Lancet Oncology 2007 8, 219-225DOI: (10.1016/S1470-2045(07)70041-4) Copyright © 2007 Elsevier Ltd Terms and Conditions